CN1103222C - External use medicinal liquid for treating psoriasis - Google Patents

External use medicinal liquid for treating psoriasis Download PDF

Info

Publication number
CN1103222C
CN1103222C CN99101524A CN99101524A CN1103222C CN 1103222 C CN1103222 C CN 1103222C CN 99101524 A CN99101524 A CN 99101524A CN 99101524 A CN99101524 A CN 99101524A CN 1103222 C CN1103222 C CN 1103222C
Authority
CN
China
Prior art keywords
medicinal liquid
parts
psoriasis
tinea
externally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99101524A
Other languages
Chinese (zh)
Other versions
CN1259354A (en
Inventor
阎福山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99101524A priority Critical patent/CN1103222C/en
Publication of CN1259354A publication Critical patent/CN1259354A/en
Application granted granted Critical
Publication of CN1103222C publication Critical patent/CN1103222C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to an externally-applied medicinal liquid for treating psoriasis, which is prepared from the traditional Chinese medicine raw materials of cantharis, arsenic powder, spirit, etc. with the functions of disinsection and sterilization according to a certain proportion. The externally-applied medicinal liquid has the advantages of simple preparation technology, obvious therapeutic effect and no relapse after cure. The externally-applied medicinal liquid can effectively treat psoriasis, stubborn tinea, tinea circinata, cruris tinea, eczema, dermatitis and various skin diseases. Through clinical observation of 31 patients with psoriasis, the cure rate reaches 96.7%.

Description

The psoriasic lotion of a kind of treatment
The present invention relates to the psoriasic lotion of a kind of treatment.
Psoriasis is a kind of common dermatomycosis, belongs to frequently-occurring disease, and medical circle is called " second cancer ".Conventional with Chinese medicine for oral administration with put on the skin outward and be coated with the liquid medicine treatment, the medicine of using always has Radix Tripterygii Wilfordii syrup, aminopterin, second span woods etc.With these Drug therapy psoriasiss, curative effect is undesirable, the relapse rate height, and obstinate makes the patient suffering unbearably.
The objective of the invention is to provide the lotion of the sick tinea of a kind of treatment Corii Bovis seu Bubali easy to use, eutherapeutic for the world of medicine.
The lotion of the sick tinea of treatment Corii Bovis seu Bubali of the present invention, preparation according to a conventional method, its component by the following weight proportioning is made:
50~80 parts of Mylabris
15~20 parts in arsenicum sablimatum powder
800~1200 parts of Chinese liquor.
The weight proportion of exemplary embodiments 1 of the present invention is: 55 parts of Mylabris, 20 parts in arsenicum sablimatum powder, 800 parts of Chinese liquor.Its preparation process is as follows: get 650 parts of Chinese liquor (be Chinese liquor total amount about 80%), 55 parts of Mylabris are broken into fine-powdered with powder of cantharide and put into described Chinese liquor bubble five days; Get 150 parts of Chinese liquor (be Chinese liquor total amount about 20%), 20 parts in arsenicum sablimatum powder was put into described Chinese liquor bubble five days with the arsenicum sablimatum powder; Two kinds of liquefied mixtures that will make then mix, and steep to be finished product liquid medicine in five days again.
The weight proportion of exemplary embodiments 2 of the present invention is: 70 parts of Mylabris, 15 parts in arsenicum sablimatum powder, 1000 parts of Chinese liquor.Its preparation process is as follows: 70 parts of fine-powdered Mylabris and arsenicum sablimatum powder are all put into 1000 parts of Chinese liquor for 15 parts, stirred 30~60 minutes with mixing plant, Mylabris and arsenicum sablimatum powder fully are dissolved in promptly make finished product liquid medicine in the Chinese liquor, deposit again after 10 days can Cantharis and the arsenicum sablimatum powder fully be dissolved in and promptly make finished product liquid medicine in the Chinese liquor, deposit again after 10 days and can use.
The weight proportion of exemplary embodiments 3 of the present invention is: 78 parts of Mylabris, 18 parts in arsenicum sablimatum powder, 1200 parts of Chinese liquor.Its preparation method all can by above-mentioned two kinds of methods.
Among the preparation technology of above-mentioned liquid medicine, described Chinese liquor can be selected sorghum wine and Chinese liquor in bulk or the like for use.Described arsenicum sablimatum powder selects for use arsenicum sablimatum frost, Arsenicum sablimatum frost all can.
Introduce in the pharmacopeia, the Mylabris suffering, heat, very toxic, energy counteracting toxic substances phagedenoma, removing blood stasis eliminating stagnation.All with micro-adapted, bactericidal effect is poor for prior art.The present invention is with an amount of Mylabris adapted arsenicum sablimatum powder, be dissolved in and make liquid medicine in the Chinese liquor, put on the skin and be applied to the psoriasis affected part, the bactericidal antiphlogistic effect significantly strengthens, can effectively treat psoriasis, stubborn dermatitis, tinea circinata, tinea cruris, eczema, dermatitis and various dermatosis, non-relapse after healing.And preparation technology is simple, and the patient is easy to use.
Liquid medicine of the present invention is through 31 routine psoriatic's clinical observations, and 30 examples are fully recovered, and cure rate reaches 96.7%.Wherein many patients are the intractable psoriatics more than 20 years, and wherein model case is as follows.
The double tower south lane resident of 35 years old Taiyuan City of case 1 Chen Gui English woman, head, upper body and lower limb were suffered from psoriasis more than 5 years, and seek medical advice and do not heal in many places.Bring into use liquid medicine treatment of the present invention 1998 days, put on the skin every day and be coated with liquid medicine once, a course of treatment two Mondays, six recoveries from illness course of treatment, not recurrence so far.
64 years old Taiyuan City of case 2 Cui Lan English woman and No. 59 residents of East St, state first word, whole body was suffered from psoriasis more than 50 year, and December in 1997 in April, 1998 patient treated five months with this liquid medicine, now fully recovered.
3 of cases man of virtue and ability's dawn 31 years old Shanxi Province of woman area, Yuci office worker of Administration of Coal Mine Safety suffers from surplus the psoriasis universalis 20 year, and it is invalid to see the doctor for treatment in many ways, begin to put on the skin in April, 98 to be coated with liquid medicine of the present invention, once a day, recovery from illness after 3 months, recurrence so far.

Claims (1)

1, the psoriasic lotion of a kind of treatment is characterized in that it is the lotion that is prepared according to a conventional method by the following weight proportion raw material:
50~80 parts of Mylabris
15~20 parts in arsenicum sablimatum powder
800~1200 parts of Chinese liquor.
CN99101524A 1999-01-04 1999-01-04 External use medicinal liquid for treating psoriasis Expired - Fee Related CN1103222C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99101524A CN1103222C (en) 1999-01-04 1999-01-04 External use medicinal liquid for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99101524A CN1103222C (en) 1999-01-04 1999-01-04 External use medicinal liquid for treating psoriasis

Publications (2)

Publication Number Publication Date
CN1259354A CN1259354A (en) 2000-07-12
CN1103222C true CN1103222C (en) 2003-03-19

Family

ID=5270497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99101524A Expired - Fee Related CN1103222C (en) 1999-01-04 1999-01-04 External use medicinal liquid for treating psoriasis

Country Status (1)

Country Link
CN (1) CN1103222C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101185686B (en) * 2007-12-11 2011-10-26 童小桃 Powder agent medicine for treating eczema
CN105708993A (en) * 2014-12-01 2016-06-29 韦健宁 Traditional Chinese medicine composition for treating dermatitis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088811A (en) * 1992-12-29 1994-07-06 李太江 Medicinal liquid for treating tinea
CN1098923A (en) * 1993-08-14 1995-02-22 陈兰君 Effective neurodermatitis medicine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088811A (en) * 1992-12-29 1994-07-06 李太江 Medicinal liquid for treating tinea
CN1098923A (en) * 1993-08-14 1995-02-22 陈兰君 Effective neurodermatitis medicine

Also Published As

Publication number Publication date
CN1259354A (en) 2000-07-12

Similar Documents

Publication Publication Date Title
CN100381151C (en) Dermatosis treating Chinese medicine prepn
CN1103222C (en) External use medicinal liquid for treating psoriasis
CN1060787A (en) The reparation technology of red medicine plaster
CN101716207B (en) Chinese medicine pigmentum for treating shingles and preparation method thereof
CN1433781A (en) Wanli ointment
CN101181427B (en) Externally used medicament for curing scaly tetter
CN1078396A (en) Medicine for treating dermatosis and manufacture method thereof
CN101336992B (en) Traditional Chinese medicine preparation for treating early burn or scald
CN1084627C (en) Traditional Chinese medicinal plaster for treating psoriasis
CN1424094A (en) Detumescence plaster
CN1075730C (en) Wind evil-dispelling, meridian passage-dredging and pus-drawing out medicine powder
CN102626479B (en) External-use Chinese herbal medicine composition for chronic rheumatism treatment
CN1259949C (en) Capsule for treating wound
CN100509052C (en) Traditional Chinese medicine preparation for treating bone spinal cord inflammation
CN1307887A (en) Medicine composite and its preparation
CN1090196A (en) Liquid for curing bone fracture
CN1506076A (en) Externally appied medicine for relieving pain and diminishing inflammation
CN101884753A (en) Medicament for treating empyrosis
CN111701001A (en) Medicine for treating gallstones and kidney stones
CN1125608A (en) Patent drug- "jiegu" powder medicine for treatment of fracture
CN102579853A (en) Chinese medicinal injection combination for treating prolapse of lumber intervertebral disc and hyperosteogeny
CN1063072C (en) Tung oil plaster for reinforcing muscles and strengthening bones
CN111789928A (en) Formula of external-use ginger-type obstinate arthralgia treating medicine
CN111759903A (en) Traditional Chinese medicine ointment for treating psoriasis
CN109172678A (en) A kind of Chinese medicine of quick treatment nervous headache

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee